Javascript must be enabled to continue!
PREPARATION AND CHARACTERIZATION OF POLYMERIC NANOPARTICLES CONTAINING METRONIDAZOLE
View through CrossRef
Background (including purposes): Periodontitis is a chronic bacterial infection destroying tooth supporting tissues. Although metronidazole exhibits a high effectiveness in the periodontitis treatment, its fast release and the usage frequency of several times per day can become obstacles for the local treatment. Therefore, nanotechnology is necessary to extend the duration of action and reduce the frequency of drug usage per day. The aim of this study was to formulate metronidazole nanoparticles by the nanoprecipitation method and to evaluate their physicochemical properties.
Materials and methods: Metronidazole, Eudragit RS100 polymer were used in this study. Nanoparticles containing metronidazole were prepared by the nanoprecipitation method. The factors of the formulation and manufacturing process of nanoparticles containing metronidazole were investigated. The resulting nanoparticles were characterized in terms of the particle size, polydispersed index (PDI), encapsulation efficiency, etc.
Results: The nanoparticles containing metronidazole were successfully prepared with the spherical shape, the particle size of 201.9 ± 5.6 nm, PDI of 0.092 ± 0.014, and entrapment efficiency of 46.28 ± 1.18%. These nanoparticles could prolong the drug release (53.45 ± 1.49% at 24 hours). The Korsmeyer-Peppas equation best described the release kinetics of the drug from metronidazole nanoparticles.
Key words: Metronidazole, nanoparticle, periodontitis
Hue University of Medicine and Pharmacy
Title: PREPARATION AND CHARACTERIZATION OF POLYMERIC NANOPARTICLES CONTAINING METRONIDAZOLE
Description:
Background (including purposes): Periodontitis is a chronic bacterial infection destroying tooth supporting tissues.
Although metronidazole exhibits a high effectiveness in the periodontitis treatment, its fast release and the usage frequency of several times per day can become obstacles for the local treatment.
Therefore, nanotechnology is necessary to extend the duration of action and reduce the frequency of drug usage per day.
The aim of this study was to formulate metronidazole nanoparticles by the nanoprecipitation method and to evaluate their physicochemical properties.
Materials and methods: Metronidazole, Eudragit RS100 polymer were used in this study.
Nanoparticles containing metronidazole were prepared by the nanoprecipitation method.
The factors of the formulation and manufacturing process of nanoparticles containing metronidazole were investigated.
The resulting nanoparticles were characterized in terms of the particle size, polydispersed index (PDI), encapsulation efficiency, etc.
Results: The nanoparticles containing metronidazole were successfully prepared with the spherical shape, the particle size of 201.
9 ± 5.
6 nm, PDI of 0.
092 ± 0.
014, and entrapment efficiency of 46.
28 ± 1.
18%.
These nanoparticles could prolong the drug release (53.
45 ± 1.
49% at 24 hours).
The Korsmeyer-Peppas equation best described the release kinetics of the drug from metronidazole nanoparticles.
Key words: Metronidazole, nanoparticle, periodontitis.
Related Results
Metronidazole Increases Intracolonic but Not Peripheral Blood Acetaldehyde in Chronic Ethanol‐Treated Rats
Metronidazole Increases Intracolonic but Not Peripheral Blood Acetaldehyde in Chronic Ethanol‐Treated Rats
Background: Metronidazole leads to the overgrowth of aerobic flora in the large intestine by reducing the number of anaerobes. According to our previous studies, this shift may in...
Antimicrobial activity of ciprofloxacin-coated gold nanoparticles on selected pathogens
Antimicrobial activity of ciprofloxacin-coated gold nanoparticles on selected pathogens
Antibiotic resistance amongst bacterial pathogens is a crisis that has been worsening over recent decades, resulting in serious and often fatal infections that cannot be treated by...
1010. Metronidazole-associated neurologic adverse events: risk factors analysis
1010. Metronidazole-associated neurologic adverse events: risk factors analysis
Abstract
Background
Metronidazole is a widely used antibiotic to treat anaerobic and protozoal infections. However, neurologic a...
Metronidazole-Induced Pancreatitis: Is There Underrecognition? A Case Report and Systematic Review of the Literature
Metronidazole-Induced Pancreatitis: Is There Underrecognition? A Case Report and Systematic Review of the Literature
Introduction. Acute pancreatitis (AP) is the most common cause of gastroenterological hospitalization in the USA, with a mortality ranging from 5 to 20%. Up to 80% of cases are cau...
P-1980. CNS Toxicity Profile of Metronidazole: A Review of Spontaneous Reports in the AERS System
P-1980. CNS Toxicity Profile of Metronidazole: A Review of Spontaneous Reports in the AERS System
Abstract
Background
Metronidazole is a widely prescribed nitroimidazole antibiotic for anaerobic and protozoal infections...
In vitro study of the interaction between artemether-lumefantrine and ciprofloxacin/metronidazole
In vitro study of the interaction between artemether-lumefantrine and ciprofloxacin/metronidazole
This study investigated the in vitro interactions between artemether-lumefantrine and ciprofloxacin or metronidazole in their co-administration. Commercial brands of artemether-lum...
Multifunctional Silver Nanoparticles: Synthesis and Applications
Multifunctional Silver Nanoparticles: Synthesis and Applications
Multifunctional silver nanoparticles have attracted widely due to their potential applications. Based on the properties of individual silver nanoparticles, such as plasmonic and an...
Hybrid Nanocomposite from γ-Fe2O3 Nanoparticles Functionalized in the Amazon Oil Polymers matrix
Hybrid Nanocomposite from γ-Fe2O3 Nanoparticles Functionalized in the Amazon Oil Polymers matrix
In recent years, there was a crescent increase in studies involving hybrid magnetic nanocomposites from renewable resources, because of its importance in the synthesis of new organ...

